A composition comprising a purified lipid cell-wall component or analog or derivative thereof and a suitable pharmaceutical carrier, medium, excipient or adjuvant is described. The composition is useful in prophylactic and therapeutic methods treating a microbial infection in a subject typically a mycobacterial infe...
Charges
55 Crore
13 March 2013
Ing Vysya Bank Limited
55 Crore
28 December 2007
State Bank Of Hyderabad
84 Crore
13 March 2013
Others
0
28 December 2007
State Bank Of Hyderabad
0
13 March 2013
Others
0
28 December 2007
State Bank Of Hyderabad
0
13 March 2013
Others
0
28 December 2007
State Bank Of Hyderabad
0
Documents
Form PAS-6-25122020_signed
Form AOC-4(XBRL)-11112020_signed
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-09112020
Form MGT-7-04102020_signed
List of share holders, debenture holders;-30092020
Copy of MGT-8-30092020
Form PAS-6-10092020_signed
Form PAS-6-01092020_signed
Form DIR-12-24082020_signed
Optional Attachment-(1)-17082020
Form MGT-14-25072020_signed
Form DIR-12-25072020_signed
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-24072020
Evidence of cessation;-24072020
Declaration of the appointee director, Managing director, in Form No. DIR-2;-24072020
Notice of resignation;-24072020
Form MGT-14-12062020_signed
Form MR-1-12062020_signed
Copy of letter of consent to act as Managing Director/ Whole time Director/Manager ; -12062020
Copy of shareholders resolution-12062020
Copy(s) of resolution(s) along with copy of explanatory statement under section 173-12062020
XBRL financial statements duly authenticated as per section 134 (including Board's report,auditor's report and other documents)-23082019
Form AOC-4(XBRL)-23082019_signed
Form MGT-7-16072019_signed
Copy of MGT-8-15072019
List of share holders, debenture holders;-15072019